Prof Naveed Sattar, a cardiometabolic medicine expert at the University of Glasgow, said far larger-scale and longer trials were now needed, not least to check safety
A concern is that an upsurge in off-label use of semaglutide will again impart further hardship on people utilising this drug for type 2 diabetes as stock is only guaranteed for expected use in [this cohort]. Moreover, Dr Deed is also wary about siloing healthcare into commercial disease-focused entities as they may impact on patients ability to manage any safety concerns or risks associated with medical advice given in these contexts
Statistical analysis and plots were performed using GraphPad Prism (v8.0) and R (v4.2.1)
Identity facts, not product claims
In the brain, prolonged oxidative stress initiates various pathological processes that play a pivotal role in AD pathology
This gradual dose escalation helps the body adjust to the medication and may help reduce side effects such as nausea and digestive discomfort